Trial intelligence / Profile preview

Ivabradine in a capsaicin-induced pain model in healthy volunteers

2012-005627-32Phase 2Terminated

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of ivabradine in Neuralgia (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Mar 2014; status: terminated.

02

Drugs

ivabradine
03

Conditions

Neuralgia

Beyond the preview

Go deeper on 2012-005627-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005627-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call